Mitch K. Goldenberg
Technik-/Wissenschafts-/F&E-Leiter bei CONCERT PHARMACEUTICALS, INC.
Aktive Positionen von Mitch K. Goldenberg
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CONCERT PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2008 | - |
Karriereverlauf von Mitch K. Goldenberg
Ausbildung von Mitch K. Goldenberg
| Rensselaer Polytechnic Institute | Undergraduate Degree |
| Harvard Extension School | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Concert Pharmaceuticals, Inc.
 Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA. | Health Technology |
- Börse
- Insiders
- Mitch K. Goldenberg
- Erfahrung
